Scandinavian Biopharma Announces Successful Completion of Pediatric Phase IIb Trial for ETVAX® Vaccine in The Gambia
Scandinavian Biopharma is pleased to announce the successful completion of its large pediatric Phase IIb trial for ETVAX®, a promising vaccine candidate against enterotoxigenic Escherichia coli (ETEC), commonly called traveler’s diarrhea, conducted in The Gambia.